Skip to Content

Pfizer STN 37.5 mg (Sutent 37.5 mg)

Generic Name: sunitinib

Pill with imprint Pfizer STN 37.5 mg is Yellow, Capsule-shape and has been identified as Sutent 37.5 mg. It is supplied by Pfizer U.S. Pharmaceuticals Group.

Sutent is used in the treatment of renal cell carcinoma; gastrointestinal stromal tumor; pancreatic cancer and belongs to the drug classes multikinase inhibitors, VEGF/VEGFR inhibitors. There is positive evidence of human fetal risk during pregnancy. Sutent 37.5 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for Pfizer STN 37.5 mg

Sutent 37.5 mg Pfizer STN 37.5 mg

Sutent

Generic Name
sunitinib
Imprint
Pfizer STN 37.5 mg
Strength
37.5 mg
Color
Yellow
Shape
Capsule-shape
Availability
Prescription only
Drug Class
Multikinase inhibitors, VEGF/VEGFR inhibitors
Pregnancy Category
D - Positive evidence of risk
CSA Schedule
Not a controlled drug
Labeler / Supplier
Pfizer U.S. Pharmaceuticals Group
National Drug Code (NDC)
00069-0830

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.